According to a study conducted by the EF-Clif published in Gastroenterology This study has shown for the first time that the administration of albumin at high doses has an immunomodulatory effect both in the short (INFECIR-2) and long-term (Pilot-PRECIOSA) in patients with decompensated cirrhosis…
A revision is proposed for current WHO guidelines for chronic hepatitis B (CHB) as they fail to detect half of the patients in need of treatment in Ethiopia
In a new study in the Journal of Hepatology, researchers report favorable 10-year survival rates for patients with HBV and/or HCV treated with antiviral agents and advise that antiviral therapy should be systematically offered to all HBV and HCV patients in line with international recommendations.
It is estimated that 2 billion people are infected with hepatitis B virus (HBV) globally, with 686,000 people dying from complications of the disease each year.
Hepatic encephalopathy (HE) is a frequent complication in patients with chronic liver disease. HE is a complication of cirrhosis that is associated with psychomotor slowing and an increased risk of accidents at home, at work, or while driving a car. Dr Formentin and colleagues aimed to evaluate t…
Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients treat…
Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was associated with a reduced risk of HCC, an effect…
SCIENTIFIC PRESS RELEASE Developing personalised targets for treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) Barcelona, Spain – An EU Horizon 2020-financed project investigating methods to better understand the role of the microbiome to help stratify patient health …
DIGESTIVE WELLNESS 14 December 2018 170,000 people in Europe die from liver failure every year. The cirrhosis death toll could be cut from 2020, thanks to advanced dialysis technology being trialled in the UK and Europe now. Many people with liver disease do not see it coming until it’s too late….
Alcoholic liver disease and nonalcoholic fatty liver disease (NAFLD) are the leading etiologies for chronic liver disease chronic-liver-disease-related deaths in the United States over the last decade, according to the results of a new study. The prevalence of nonalcoholic fatty liver disease— a …
